Tourmaline Bio (TRML) Short Interest Ratio & Short Volume → Read this before you buy AI stocks (From InvestorPlace) (Ad) Free TRML Stock Alerts $14.73 -0.31 (-2.06%) (As of 02:14 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Tourmaline Bio Short Interest DataCurrent Short Interest3,110,000 sharesPrevious Short Interest1,790,000 sharesChange Vs. Previous Month+73.74%Dollar Volume Sold Short$49.23 millionShort Interest Ratio7.4 Days to CoverLast Record DateApril 30, 2024Outstanding Shares25,650,000 sharesFloat Size15,460,000 sharesShort Percent of Float20.12%Today's Trading Volume94,651 sharesAverage Trading Volume362,525 sharesToday's Volume Vs. Average26% Short Selling Tourmaline Bio ? Sign up to receive the latest short interest report for Tourmaline Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTRML Short Interest Over TimeTRML Days to Cover Over TimeTRML Percentage of Float Shorted Over Time Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. Tourmaline Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,110,000 shares $49.23 million +73.7%20.1%7.4 $15.83 4/15/20241,790,000 shares $33.99 million +21.0%11.6%4.1 $18.99 3/31/20241,480,000 shares $33.89 million +123.1%9.6%4.1 $22.90 3/15/2024663,500 shares $28.66 million -14.9%4.3%2 $43.19 2/29/2024779,800 shares $30.27 million +14.0%5.1%3.5 $38.82 2/15/2024684,000 shares $26.95 million +47.6%4.4%3.4 $39.40 1/31/2024463,500 shares $15.48 million No Change2.9%2.8 $33.39 TRML Short Interest - Frequently Asked Questions What is Tourmaline Bio's current short interest? Short interest is the volume of Tourmaline Bio shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 3,110,000 shares of TRML short. 20.12% of Tourmaline Bio's shares are currently sold short. Learn More on Tourmaline Bio's current short interest. What is a good short interest ratio for Tourmaline Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TRML shares currently have a short interest ratio of 7.0. Learn More on Tourmaline Bio's short interest ratio. What is a good short interest percentage for Tourmaline Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 20.12% of Tourmaline Bio's floating shares are currently sold short. Is Tourmaline Bio's short interest increasing or decreasing? Tourmaline Bio saw a increase in short interest in April. As of April 30th, there was short interest totaling 3,110,000 shares, an increase of 73.7% from the previous total of 1,790,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tourmaline Bio's float size? Tourmaline Bio currently has issued a total of 25,650,000 shares. Some of Tourmaline Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tourmaline Bio currently has a public float of 15,460,000 shares. How does Tourmaline Bio's short interest compare to its competitors? 20.12% of Tourmaline Bio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Tourmaline Bio: Sutro Biopharma, Inc. (2.38%), Atea Pharmaceuticals, Inc. (2.43%), Prelude Therapeutics Incorporated (2.43%), Repare Therapeutics Inc. (2.38%), Nuvation Bio Inc. (2.51%), Zentalis Pharmaceuticals, Inc. (24.64%), Bicycle Therapeutics plc (6.52%), Scholar Rock Holding Co. (16.78%), Anavex Life Sciences Corp. (25.15%), Terns Pharmaceuticals, Inc. (10.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Tourmaline Bio stock? Short selling TRML is an investing strategy that aims to generate trading profit from Tourmaline Bio as its price is falling. TRML shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tourmaline Bio? A short squeeze for Tourmaline Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TRML, which in turn drives the price of the stock up even further. How often is Tourmaline Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRML, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: STRO Short Squeeze AVIR Short Squeeze PRLD Short Squeeze RPTX Short Squeeze NUVB Short Squeeze ZNTL Short Squeeze BCYC Short Squeeze SRRK Short Squeeze AVXL Short Squeeze TERN Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TRML) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldBiden Nomination CANCELED?The Freeport SocietyDoes this make you sick?Allegiance GoldDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlace